Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial - Davidson, Michael H; Hauptman, Jonathan; DiGirolamo, Mario; Foreyt, John P; Halsted, Charles H; Heber, David; Heimburger, Douglas C; Lucas, Charles P; Robbins, David C; Chung, Jain; Heymsfield, Steven B (JAMA : the journal of the American Medical Association, 1999)
Keywords: Adult; Analysis of Variance; Biological and medical sciences; Blood Glucose; Blood Pressure; Cardiovascular Diseases - etiology; Cardiovascular Diseases - prevention & control; Double-Blind Method; Drug therapy; Energy Intake; Enzyme Inhibitors - therapeutic use; Female; Follow-Up Studies; General and cellular metabolism. Vitamins; Health risk assessment; Humans; Insulin - blood; Lactones - therapeutic use; Lipase - antagonists & inhibitors; Lipids - blood; Male; Medical sciences; Obesity; Obesity - complications; Obesity - diet therapy; Obesity - drug therapy; Obesity - metabolism; Orlistat; Pharmacology. Drug treatments; Risk Factors; Weight control; Weight Loss; United States; North America; America; Human; Evaluation; Obesity; Nutrition disorder; Weight loss; Metabolic diseases; Controlled therapeutic trial; Prevention; Chemical reduction; Randomization; Association; Diet therapy; Risk factor; Orlistat; Public health; Nutritional status; Antilipemic agent